Curio Science

6 posts

Curio Science banner
Curio Science

Curio Science

@_CurioScience_

Scientific exchange and insights gathering agency focused on healthcare professionals in oncology and hematology. Curio Science, a Vaniam Group company

शामिल हुए Kasım 2019
174 फ़ॉलोइंग187 फ़ॉलोवर्स
Curio Science रीट्वीट किया
Vaniam Group LLC
Vaniam Group LLC@VaniamGroup·
Our @_CurioScience_ team drives expert-led exchanges with HCPs to gain insights on practice patterns, clinical data, & their impact on decisions across rare diseases. Together, let's advance healthcare and improve outcomes. #RareDiseaseDay Learn more: loom.ly/vE_QtCg
Vaniam Group LLC tweet media
English
0
1
0
236
Curio Science रीट्वीट किया
Curio Science रीट्वीट किया
Nausheen Ahmed MD
Nausheen Ahmed MD@NausheenAhmedMD·
@_CurioScience_ Opinions in hematologic malignancies: overview of the fields of MM and Lymphoma. It is not surprising that docs feel that #access for Cell therapy is an issue. Evolving field with #Cart #bispecifics . Highlight of the meeting was meeting @szusmani below 👇
Nausheen Ahmed MD tweet media
English
1
5
21
2.4K
Curio Science रीट्वीट किया
C. Ola Landgren, M.D.
C. Ola Landgren, M.D.@DrOlaLandgren·
Great heme-malignancy meeting by @_CurioScience_ in Marco Island, FL. Teamwork with longterm friends @SagarLonialMD @szusmani @Dr_AdrianaRossi @myelomatips. Focus on “novel immunotherapies in myeloma”. Fun discussions. Full house! #mmsm @IMFmyeloma @theMMRF @HealthtreeMM
C. Ola Landgren, M.D. tweet media
Saad Z. Usmani MD MBA FASCO 🇺🇸🇵🇰@szusmani

@DrOlaLandgren covering BCMA directed therapies, highlighting exceptional single agent activity of CARs, BsAbs and also summarizing that Belamaf combos may have a future in RRMM. Cases and Q/A to cover safety/practical considerations coming up soon #mmsm @_CurioScience_ at Opinions in Hematologic Malignancies

English
1
1
24
3.2K